gavin
Forum Topics Started
-
- Topic
- Voices
- Last Post
-
- TAIHO ONCOLOGY ANNOUNCES UPDATED EFFICACY AND SAFETY DATA FOR FUTIBATINIB IN CHO
- 1
- 2 years, 1 month ago
- Low preoperative psoas muscle mass index is a risk factor for distal cholangioca
- 1
- 2 years, 1 month ago
- Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarc
- 1
- 2 years, 1 month ago
- A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully T
- 3
- 2 years, 1 month ago
- Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Surviv
- 1
- 2 years, 1 month ago
- An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for
- 1
- 2 years, 1 month ago
- Toripalimab combined with gemcitabine and S-1 in the first-line treatment of adv
- 1
- 2 years, 1 month ago
- A phase Ib, open-label, multi-cohort study of metronomic capecitabine plus camre
- 1
- 2 years, 1 month ago
- Genomic determinants and clinical relevance of cancer-associated thrombosis in b
- 1
- 2 years, 1 month ago
- Comprehensive molecular characterization of Chinese patients with biliary tract
- 1
- 2 years, 1 month ago
- A phase 1b/2, dose-escalation, randomized, multicenter study of maintenance (mai
- 1
- 2 years, 1 month ago
- Design and rationale of a first-in-human (FIH) phase 1/1b study evaluating KIN-3
- 1
- 2 years, 1 month ago